lactic acid has been researched along with aripiprazole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nahata, T; Saini, TR | 1 |
| Itoh, M; Kaneko, YS; Kondo, K; Mori, K; Nagasaki, H; Nagatsu, T; Nakashima, A; Ota, A; Ota, M; Takayanagi, T | 1 |
| Hiraoka, S; Namiki, N; Uchida, S | 1 |
| Izumi, T; Kondo, K; Nakashima, A; Niwa, T; Ohya, K | 1 |
| Kaur, L; Sinha, VR | 1 |
5 other study(ies) available for lactic acid and aripiprazole
| Article | Year |
|---|---|
D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Cholesterol; Delayed-Action Preparations; Lactic Acid; Microspheres; Particle Size; Piperazines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Quinolones; Schizophrenia; Solubility; Solvents | 2008 |
Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antipsychotic Agents; Apoptosis; Aripiprazole; Carbon; Cell Survival; Clozapine; Dihydrolipoamide Dehydrogenase; Dose-Response Relationship, Drug; Electron Transport Complex IV; Extracellular Fluid; Gene Expression Regulation, Enzymologic; Glucose; Glycolysis; Hypoxanthine Phosphoribosyltransferase; Isocitrate Dehydrogenase; Ketone Oxidoreductases; Lactic Acid; Membrane Potential, Mitochondrial; NAD; Oxidoreductases; PC12 Cells; Piperazines; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvic Acid; Quinolones; Rats; RNA, Messenger; Time Factors | 2012 |
Preparation and characterization of high-content aripiprazole-loaded core-shell structure microsphere for long-release injectable formulation.
Topics: Animals; Aripiprazole; Chemistry, Pharmaceutical; Crystallization; Delayed-Action Preparations; Isomerism; Lactic Acid; Microspheres; Molecular Weight; Piperazines; Polyesters; Polymers; Porosity; Quinolones; Rabbits; Temperature; Viscosity | 2014 |
Design of Highly Dispersible PLGA Microparticles in Aqueous Fluid for the Development of Long-Acting Release Injectables.
Topics: Aripiprazole; Delayed-Action Preparations; Drug Carriers; Freeze Drying; Injections; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Long Acting Polycaprolactone Based Parenteral Formulation of Aripiprazole Targeting Behavioural and Biochemical Deficit in Schizophrenia.
Topics: Animals; Aripiprazole; Delayed-Action Preparations; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyesters; Rats; Schizophrenia | 2021 |